Twitter Delicious Facebook Digg Stumbleupon Favorites More

Positive trends at ECO Animal Health (Eco news)

Positive trends at ECO Animal Health
Proactive Investors UK reported

ECO Animal Health Group (LON:EAH), which makes environmentally-friendly drugs for livestock, said that trading in its current financial year has started well with “positive trends being seen” in many of its key markets.

The firm also announced that its results for the year to 31 March would be released on 25 July.

ECO, one of AIM’s longest-standing companies (it has been traded on London’s junior market since 1995 when it was known as Lawrence plc), was expected to deliver a 30 percent increase in revenues to £28.3 million for its 2011 financial year along with an adjusted pre-tax profit of £3.1 million, according to estimates made earlier this year house broker Cenkos Securities.

Accounting for almost 60 percent of ECO Animal Health’s sales, the group’s flagship product Aivlosin is a drug containing the animal antibiotic tylvalosin.

It is rapidly absorbed by animals and concentrates in target tissues to provide control of major respiratory and enteric diseases in both pigs and poultry. So far, it is licensed only for respiratory and enteric bacterial diseases in pigs and poultry, but the drug has potential to be used for other purposes.

ECO Animal Health’s range also includes Ecomectin, which is its second-biggest selling product. This endectocide is used for a broad range of parasite control, including the treatment and control of gastro-intestinal roundworms, lungworms, grubs, horn flies, sucking and biting lice as well as mites.


Post a Comment

Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Blogger Templates